Healthy condition
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Healthy person aged 18 and under 30 2) Those who can attend the study site within the study period 3) Persons who can get written consent for participation in this study
Exclusion criteria
Exclusion criteria: 1) Persons who go to the hospital or take medication for basic diseases (chronic respiratory diseases, heart diseases, kidney diseases, liver diseases, diabetes, blood diseases (hyponatremia, difficult-to-treat high blood pressure, etc.), immune function Decreasing illnesses (including malignant tumors), neurological disorders, neuromuscular disorders and severe mental illnesses) 2) Persons who complain of poor physical condition due to sleep disorders 3) Persons who have a habit of excessive smoking * 1 and excessive alcohol intake * 2, and those who have an extremely irregular diet * 3 4) Those who donated 400 ml of blood within 12 weeks, 200 ml of blood within 4 weeks, and component blood within 2 weeks before the start of the experiment 5) Persons participating in other clinical trials <Notes> * 1 Excessive smoking generally means smoking 21 or more cigarettes a day. * 2 Excessive alcohol intake is roughly equivalent to 2 cups of sake per day (500 ml of beer bottle x 2 bottles, whiskey double 60 ml x 2 cups, 1 go of shochu 180 ml, 1 cup of red wine glass 60 ml x 7 cups) or more. Refers to drinking. * 3 Refers to a state in which one or more meals a day are one or more meals, and the meal time is constantly irregular.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of the electrocardiogram (ECG): Electrodes are placed on the chest induction I and recordings are made. The instantaneous heart rate, QT interval, QTc interval are calculated from the recorded ECG. In addition, HRV analysis is performed as an indicator of cardiac autonomic function. The ECG is measured for 10 minutes before stimulation, 2 minutes during stimulation, and 15 minutes after stimulation, for a total of 27 minutes. | — |
Secondary
| Measure | Time frame |
|---|---|
| Measurement of the finger plethysmogram: A pulse transducer (MP100, AD Instruments) is attached to the tip of the right index finger to record and calculate wave height values. Measurement of the local skin blood flow: A laser Doppler skin blood flow meter (ALF-21, Advance) is used to fix the probe near the stimulation site and record the results. The finger plethysmogram and the local skin blood flow are measured for 10 minutes before stimulation, 2 minutes during stimulation, and 15 minutes after stimulation, for a total of 27 minutes. Assessment of the type of pain: The presence or absence of "pain" or "de qi" during the stimulation will be assessed after the end of the experiment. Evaluation of the degree of pain: The intensity of the "pain" or "de qi" is assessed using a visual analogue scale (VAS) of 10 cm in width, respectively, with 100 points as the most intense pain on a scale of every 1 mm, and 0 as the scale indicating no pain. | — |
Countries
Japan
Contacts
Teikyo Heisei University Department of Acupuncture and Moxibustion, Graduate School of Health Sciences